Month: March 2021

STAT+: The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research

American taxpayers may have provided $162 million toward researching remdesivir, but the federal government does not have patent rights for the drug because the work contributed by U.S. scientists did not generate any inventive new uses, according to a government report. Moreover, Gilead Sciences, which discovered remdesivir, had already reached collaborative research deals with various […]

Opinion: Jason Karlawish and an Alzheimer’s caregiver on dementia’s ripple effect

In this week’s “First Opinion Podcast,” I speak with Alzheimer’s expert Jason Karlawish, director of Penn’s Memory Center, about his recent First Opinion, “The long, exhausting reach of dementia care.” We were joined by Richard Bartholomew, the husband and caretaker of one of his patients. They share the isolating, all-encompassing experience of caring for a […]

STAT+: Data for Delcath’s liver tumor device are positive, but lingering questions cloud path to approval

Delcath Systems said Wednesday that its liver-tumor treatment device achieved the primary goal of a late-stage clinical trial, but questions about the strength of the data — and whether the results will satisfy regulators — caused the small company’s stock price to fall. The Delcath device, called Hepzato, consists of clamps, tubes, and a filter […]

Opinion: In light of anti-Asian attacks, medicine needs to listen to Asian American trainees

The shocking shooting rampage in Atlanta targeting Asian spas, followed not long after by an attack on a 65-year-old Asian American woman in Midtown Manhattan this week, felt to us like the culmination of a year of increased hatred, a year of Asian American and Pacific Islander people clamoring for recognition when our suffering wasn’t […]

STAT+: Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a cool breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. […]

Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents

Pfizer and BioNTech said Wednesday that their Covid-19 vaccine prevented symptomatic disease and was well-tolerated in a Phase 3 study of adolescents ages 12 to 15. The companies say they will submit the data to the Food and Drug Administration as an amendment to the vaccine’s emergency use authorization, and will also submit the results […]

Scroll to top